Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven Taking Troriluzole Into Phase III OCD Study Despite Phase II/III Miss
Jun 25 2020
•
By
Mandy Jackson
Troriluzole was numerically but not statistically better than placebo • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D